Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial Article

Gilbert, Mark R, Wang, Meihua, Aldape, Kenneth D et al. (2013). Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial . Journal of Clinical Oncology, 31(32), 4085-+. 10.1200/JCO.2013.49.6968

Open Access International Collaboration

cited authors

  • Gilbert, Mark R; Wang, Meihua; Aldape, Kenneth D; Stupp, Roger; Hegi, Monika E; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara; Baumert, Brigitta; Hopkins, Kristen I; Tzuk-Shina, Tzahala; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P

sustainable development goals

authors

publication date

  • November 10, 2013

published in

keywords

  • CANCER
  • COMBINATION
  • INACTIVATION
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMA
  • MGMT
  • Oncology
  • RECURRENT
  • Science & Technology
  • THERAPY
  • VALIDATION

Digital Object Identifier (DOI)

start page

  • 4085

end page

  • +

volume

  • 31

issue

  • 32